Large cap update – FY 2024
Hugh Giddy discusses the 2024 financial year performance of IML’s large cap funds....
Small cap update – FY 2024
In our latest podcast episode, Simon Conn discusses the performance of IML small and mid cap funds for financial year 2024....
Is this small cap in the fast lane to the ASX 300?
In our latest podcast episode, discover why Generation Development Group is IML's stock of the month with Lucas Goode, Portfolio Manager...
Why has ResMed rocketed up and is the ride over?
In our latest podcast episode, discover insights on ResMed's stock analysis and the impact of Ozempic and GLP-1 drugs with Senior Equity...
Look beyond market darlings for AI winners
AI has easily been the hottest topic in investing this year. While IML's Daniel Moore is excited about its potential, he is cautious of...